Spasticity and Its Contribution to Hypertonia in Cerebral Palsy

Spasticity is considered an important neural contributor to muscle hypertonia in children with cerebral palsy (CP). It is most often treated with antispasticity medication, such as Botulinum Toxin-A. However, treatment response is highly variable. Part of this variability may be due to the inability...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Biomed Res Int
Huvudupphovsmän: Bar-On, Lynn, Molenaers, Guy, Aertbeliën, Erwin, Van Campenhout, Anja, Feys, Hilde, Nuttin, Bart, Desloovere, Kaat
Materialtyp: Artigo
Språk:Inglês
Publicerad: Hindawi Publishing Corporation 2015
Ämnen:
Review Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4306250/
https://ncbi.nlm.nih.gov/pubmed/25649546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/317047
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk